News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Glenmark Pharmaceuticals in Talks to Sell Its Oral Contraceptive Unit



10/4/2013 8:06:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mumbai-based Glenmark Pharmaceuticals is in talks to sell its oral contraceptive product division, ET states. The company is in talks with many local and global drugmakers. Along with domestic players such as Sun Pharma and Lupin, global companies Teva, Actavis and Sandoz also might be interested in acquiring the entire product range to consolidate their position in the U.S market.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at EconomicTimes


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES